The global oncolytic virus therapy market is anticipated to grow at a considerable CAGR of over 15% during the forecast period (2021-2027). Oncolytic virus therapy is a promising therapeutic approach for the treatment of cancer. These oncolytic viruses destroy the cancerous cell as well as prevent the growth of tumor cells by stimulating the host anti-tumor immune responses.
The first oncolytic virus therapy was approved in 2015, it is still is in the nascent stage of being considered a suitable and effective cancer therapy. The first oncolytic virus was the genetically modified herpes simplex virus type I that is Talimogene laherparepvec (T-VEC) that reported to be clinically beneficial for patients with melanoma. The oncolytic virus therapy market is anticipated to grow at a decent growth rate during the forecast period.
Browse the full report description of "Oncolytic Virus Therapy Market by Product (HSV-Based Oncolytic Viruses, Adenoviruses-Based Oncolytic Viruses, and Others), By Application (Melanoma and Others) - Global Industry Share, Growth, Competitive Analysis and Forecast Period 2021-2027" at https://www.omrglobal.com/industry-reports/oncolytic-virus-therapy-market
Most of the oncolytic virus therapy in clinical trials is in the preclinical phase followed by Phase-I trials. At present, two-three oncolytic drugs have been commercialized, however, around 48 oncolytic virus therapies are in clinical trials. The factors that are fuelling the growth of the market include the higher incidence and prevalence rate of cancer coupled with the advent of new treatment options.
Market Coverage
o By Application
o By Product
o North America
o Europe
o Asia-Pacific
o Rest of the World
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Oncolytic Virus Therapy Market Report Segment
By Product
By Application
Global Oncolytic Virus Therapy Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/oncolytic-virus-therapy-market